Cargando…
Adverse Events Following Immunization Among Children Under Two Years of Age: A Prospective Observational Study From North India
Background: Vaccination is one of the most cost-effective child survival health interventions. A single serious adverse event following immunization (AEFI) or a cluster of events may lead to a loss of public confidence in the program and a major setback to immunization coverage. This study was condu...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229756/ https://www.ncbi.nlm.nih.gov/pubmed/37266060 http://dx.doi.org/10.7759/cureus.38356 |
_version_ | 1785051343137800192 |
---|---|
author | Mittal, Sneha Rawat, CMS Gupta, Amit Solanki, Hariom K Singh, RK |
author_facet | Mittal, Sneha Rawat, CMS Gupta, Amit Solanki, Hariom K Singh, RK |
author_sort | Mittal, Sneha |
collection | PubMed |
description | Background: Vaccination is one of the most cost-effective child survival health interventions. A single serious adverse event following immunization (AEFI) or a cluster of events may lead to a loss of public confidence in the program and a major setback to immunization coverage. This study was conducted to assess the incidence of AEFIs in children less than two years of age. Material and Methods: A prospective community-based observational study was conducted in the North Indian state of Uttarakhand from October 2017 to February 2018. A total of 255 children who attended the selected sub-centres for immunization were finally included in the study. Follow-up home visits on the 8th and 30th day of vaccination were carried out to identify any occurrences of AEFIs. Results: Among 255 children, 212 AEFIs from 152 vaccinated subjects were reported. The majority of the AEFIs were reported in the age group 0-1 years. The incidence of AEFIs was 33.0 per 100 doses of vaccines administered. The most common AEFI reported was fever (101, 47.6%), followed by swelling (53, 25.0%). Among the vaccines, Pentavalent + oral polio vaccine (OPV) (48.8 per 100 doses) was majorly responsible for AEFIs, followed by diphtheria pertussis tetanus (DPT) + measles and rubella (MR) + OPV (46.6 per 100 doses). Conclusion: Our findings revealed that although the incidence of AEFI reported was high, all of them were minor and no serious AEFIs were identified. The awareness among health professionals and the public regarding the reporting of AEFIs should be continued to increase the safety profile of vaccines. |
format | Online Article Text |
id | pubmed-10229756 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-102297562023-06-01 Adverse Events Following Immunization Among Children Under Two Years of Age: A Prospective Observational Study From North India Mittal, Sneha Rawat, CMS Gupta, Amit Solanki, Hariom K Singh, RK Cureus Preventive Medicine Background: Vaccination is one of the most cost-effective child survival health interventions. A single serious adverse event following immunization (AEFI) or a cluster of events may lead to a loss of public confidence in the program and a major setback to immunization coverage. This study was conducted to assess the incidence of AEFIs in children less than two years of age. Material and Methods: A prospective community-based observational study was conducted in the North Indian state of Uttarakhand from October 2017 to February 2018. A total of 255 children who attended the selected sub-centres for immunization were finally included in the study. Follow-up home visits on the 8th and 30th day of vaccination were carried out to identify any occurrences of AEFIs. Results: Among 255 children, 212 AEFIs from 152 vaccinated subjects were reported. The majority of the AEFIs were reported in the age group 0-1 years. The incidence of AEFIs was 33.0 per 100 doses of vaccines administered. The most common AEFI reported was fever (101, 47.6%), followed by swelling (53, 25.0%). Among the vaccines, Pentavalent + oral polio vaccine (OPV) (48.8 per 100 doses) was majorly responsible for AEFIs, followed by diphtheria pertussis tetanus (DPT) + measles and rubella (MR) + OPV (46.6 per 100 doses). Conclusion: Our findings revealed that although the incidence of AEFI reported was high, all of them were minor and no serious AEFIs were identified. The awareness among health professionals and the public regarding the reporting of AEFIs should be continued to increase the safety profile of vaccines. Cureus 2023-04-30 /pmc/articles/PMC10229756/ /pubmed/37266060 http://dx.doi.org/10.7759/cureus.38356 Text en Copyright © 2023, Mittal et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Preventive Medicine Mittal, Sneha Rawat, CMS Gupta, Amit Solanki, Hariom K Singh, RK Adverse Events Following Immunization Among Children Under Two Years of Age: A Prospective Observational Study From North India |
title | Adverse Events Following Immunization Among Children Under Two Years of Age: A Prospective Observational Study From North India |
title_full | Adverse Events Following Immunization Among Children Under Two Years of Age: A Prospective Observational Study From North India |
title_fullStr | Adverse Events Following Immunization Among Children Under Two Years of Age: A Prospective Observational Study From North India |
title_full_unstemmed | Adverse Events Following Immunization Among Children Under Two Years of Age: A Prospective Observational Study From North India |
title_short | Adverse Events Following Immunization Among Children Under Two Years of Age: A Prospective Observational Study From North India |
title_sort | adverse events following immunization among children under two years of age: a prospective observational study from north india |
topic | Preventive Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229756/ https://www.ncbi.nlm.nih.gov/pubmed/37266060 http://dx.doi.org/10.7759/cureus.38356 |
work_keys_str_mv | AT mittalsneha adverseeventsfollowingimmunizationamongchildrenundertwoyearsofageaprospectiveobservationalstudyfromnorthindia AT rawatcms adverseeventsfollowingimmunizationamongchildrenundertwoyearsofageaprospectiveobservationalstudyfromnorthindia AT guptaamit adverseeventsfollowingimmunizationamongchildrenundertwoyearsofageaprospectiveobservationalstudyfromnorthindia AT solankihariomk adverseeventsfollowingimmunizationamongchildrenundertwoyearsofageaprospectiveobservationalstudyfromnorthindia AT singhrk adverseeventsfollowingimmunizationamongchildrenundertwoyearsofageaprospectiveobservationalstudyfromnorthindia |